European Partnership on Personalised Medicine

Last updated: 21.7.2025
Grant

The European Partnership on Personalised Medicine (HORIZON-HLTH-2023-CARE-08-01) is a Horizon Europe co-funded initiative aimed at accelerating the development and implementation of personalised medicine across Europe and beyond. This program fosters collaborative research and innovation to transform healthcare systems, ensuring equitable access to innovative, sustainable, and high-quality health solutions tailored to individual needs.

Who is Funded

This section details the eligibility criteria for applicants, the geographical scope of the program, and its core objectives in advancing personalised medicine. It outlines the diverse range of entities and regions targeted, emphasizing the program's strategic aims to enhance healthcare systems globally.

What is Funded

This section outlines the types of projects and thematic areas supported by the program, clarifying eligible costs and the typical maturity levels of projects targeted. The focus is on innovative, evidence-based solutions that transform healthcare towards a personalised approach.

Type and Scope of Funding

This section details the financial mechanisms and limits of the program, specifying the nature of the financial support, the maximum available funding, and typical project durations.

Conditions and Requirements

This section outlines the essential rules and criteria that applicants and beneficiaries must adhere to for participation and successful project execution. These encompass application terms, collaboration guidelines, budget stipulations, and other key provisions.

Application Procedure

This section outlines the process for submitting applications, including how proposals are evaluated and decisions are communicated.

This section identifies the foundational legal documents and overarching regulations that establish and govern the European Partnership on Personalised Medicine, ensuring its legitimacy and guiding its operational framework.

Similar Programs

#Personalised Medicine#European Partnership#Healthcare Innovation#Horizon Europe#Disease Prevention#Diagnosis#Treatment#Health Systems Transformation#Research and Innovation Funding#Digital Health#Patient-Centred Care#Sustainable Healthcare#EU Funding#Medical Technologies#Clinical Applications#Market Uptake#International Cooperation#Health Policy

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

100,000,000 €

Allocated Budget

Allocated Budget:

100,000,000 €

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union, Horizon Europe Associated Countries, United States of America, and other third countries wanting to join.

Sectors

Sectors:

Healthcare, Research and Development, Information and Communication Technology, Medical Technology, Service Sector, Environmental and Climate Protection

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Commercialization, Policy Development, Implementation, Capacity Building, Awareness Campaigns, Other

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

0 x 0
XS